The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses.
AstraZeneca made headlines on Tuesday as it initiated the global withdrawal of its COVID-19 vaccine. This decision comes weeks after the pharmaceutical giant acknowledged the vaccine's potential ...
Here’s a guide to our coverage of the facts ... Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine A rare risk of dangerous blood clots associated with the AstraZeneca ...
“At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccine in adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccin ...
A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...
The pharmaceutical giant AstraZeneca 's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous ...
Influenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7 and 15.3%, respectively, among health care personnel at ...
While the inquiry gets most things right, as vaccine experts, we argue the government response should be broadened in three ...
On April 30, AstraZeneca admitted that the vaccine, sold under the name Vaxzevria, can cause fatal blood clots and low platelet counts, also known as thrombosis syndrome with thrombocytopenia ...
With a portfolio containing a number of vaccines, GSK has been working for some years on the question of adult vaccination and why immunisation rates are falling, particularly in those over 50 ...
This column, forecasting a Trump election win, last week expressed surprise so many news consumers remain loyal to media ...
FluMist, produced by European pharmaceutical company and Covid vaccine-maker AstraZeneca ... may cost less depending a ...